05 Compliance

The regulatory file for collagen tripeptide

Technical document 05 · Reviewed 2026-11-20 · Collagen Tripeptide

On this page
  1. What the file has to hold
  2. European Union
  3. United States
  4. Contaminants and the finished dose
  5. Naming the ingredient and the quantity
  6. Composition descriptors and health claims
  7. The document set
  8. Before the first order

Collagen tripeptide is a food ingredient made from collagen, and its regulatory file turns on the source, the fraction and the market. The specification and the certificate describe what is in the drum; the file has to show where it came from, how it may be used and how the label will read. That route is confirmed by the buyer's regulatory team, market by market.

In one line

The specification describes the fraction; the regulatory file shows the source, the permitted use and the label for the destination.

What the file has to hold

Four records sit at the centre of the file: the current specification for the tripeptide fraction, the certificate for the lot, the destination's rules on use and labelling, and a change-control log covering source, process and pack. The COA accounts for the lot, the TDS for the specification and the SDS for handling. None of them decides whether the material can be sold in a given country.

Supporting documents sit around those four: the species and tissue declaration, the allergen statement, the GMO statement, the origin record, and any processing-aid or residual-solvent declaration the route requires. A missing item is easier to close at quotation than after the drum has been quarantined, so keep a versioned checklist at the front of the folder.

Two attributes distinguish this product from a generic collagen peptide file. The source determines the allergen and the label vocabulary, and the fraction determines the specification lines that must match the claim. A file that names neither is not yet a file for collagen tripeptide.

European Union

For a supplement sold in the EU, two questions come first: is the material permitted, and how must it be described? The labelling rules sit in Regulation (EU) No 1169/2011; contaminant limits sit in Commission Regulation (EU) 2023/915 as of this review. Collagen peptides have no harmonised maximum use level, so the intake assessment for the finished product, not the ingredient specification, fixes the grams per serving.

Novel-food status is checked for the exact source and process in the EU Novel Food Catalogue before the first shipment. A well-established collagen hydrolysate is not automatically the same case as a new source or a new fractionation route, and the entry that applies has to match the material actually placed on the market.

Fish is the allergen to watch. Where the collagen is fish-derived, Annex II of Regulation (EU) No 1169/2011 applies, and the exemptions for gelatine carriers and fining agents are tied to those specific uses. A hydrolysed fish collagen in a supplement does not inherit them by default; the label review decides and records the answer with the order.

United States

In the US, the starting question is the dietary-ingredient basis the supplier relies on and whether that basis covers the finished product. The supplier names the basis and supplies the document behind it; the buyer checks the intended use and the claim against it. The certificate supports the material, not the regulatory position.

The Supplement Facts panel names the dietary ingredient and declares the quantity as sold. If the collagen is fish-derived, the major food allergen declaration applies to dietary supplements, so the fish statement belongs in the panel and not only in the specification. Structure/function wording needs substantiation and the DSHEA disclaimer, and no disease claim is available in this market.

Contaminants and the finished dose

The metal panel is measured on the ingredient but assessed on the finished product. The references below are a starting point for a supplement dossier; the market text and the daily intake fix the final number.

Contaminant references to confirm for the finished product
ParameterReference for a supplementEvidence the file needs
Lead (Pb)3.0 mg/kgMeasured result, method, release limit and dose conversion
Cadmium (Cd)1.0 mg/kgMeasured result plus any category exception
Mercury (Hg)0.10 mg/kgMeasured result and the analytical method
Arsenic (As)Customer or market limitThe limit both sides agreed, with its method

The ingredient specification carries Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. Those limits are not interchangeable with the finished-product references, because the calculation passes through the grams per serving. A 500 mg capsule and a 5 g stick can use the same lot and still place different amounts of a metal in the product.

Naming the ingredient and the quantity

The label must use the name the destination allows and state the source where the market requires it. “Collagen tripeptide” is a technical description of the fraction; whether it may stand alone, or must appear alongside “hydrolysed collagen”, is a question for the destination's label reviewer.

The declared quantity is the mass of the ingredient, not the mass of tripeptide. One gram of collagen tripeptide certified at 30.0% tripeptide contains about 300 mg of tripeptide, and that calculation belongs in the product file. If the brand wants a tripeptide quantity on the label, the batch figure, the serving size and the label text all have to agree.

Composition descriptors and health claims

A statement about tripeptide content or molecular size is a description of composition, provided it is accurate, supported by the certificate and not misleading. “Tripeptide” or “low molecular weight” is defensible only when the method and the figure are on the specification. A descriptor without that backing is a claim waiting to be challenged.

Absorption, bioavailability or “fast uptake” wording is a different category. It needs evidence for the finished product, and in some markets it is a health claim. That review belongs to the brand and its regulatory adviser, not to the ingredient page. This site publishes the specification and makes no health claim; no disease-related claim is made in this document.

The document set

Start with the lot certificate: protein with its factor, tripeptide and peptide results with methods, loss on drying, ash, metals and micro. Add the specification with the tripeptide floor and peptide content, the source species and tissue, the TDS, the SDS, the allergen and GMO statements and the origin record. Where the source is bovine, include the TSE/BSE statement; where the process or the granulation uses a solvent or an aid, add the declaration for it.

Species PCR is an extra, not a routine release line. It is worth requesting for a new source, a first shipment or a disputed lot. The identity page explains what each test proves, and the EU regulatory notes gather the framework references.

Before the first order

  • The specification names the fraction, the tripeptide floor, the peptide content and the source.
  • The lot file holds the COA, TDS, SDS, allergen, GMO, origin and, where relevant, TSE/BSE statements.
  • The novel-food position has been checked for the exact source and process, for an EU destination.
  • The metal results have been converted to the finished dose.
  • The label and claims have been reviewed for the destination, including the fish allergen where it applies.
  • Source, fractionation and pack are covered by change notification.

The catalogue specification sits on the collagen tripeptide product page, and the release file is described on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation